Addition of romiplostim to immunosuppressive therapy as first-line treatment for patients with aplastic anemia

Jong Wook Lee; Jun Ho Jang; Hirohito Yamazaki; Masashi Sawa; Masahiro Kizaki; Yoshiaki Tomiyama; Koji Nagafuji; Kensuke Usuki; Jyh Pyng Gau; Yasuyoshi Morita; Jih Luh Tang; Hung Chang; Masayoshi Noshiro; Akira Matsuda; Keiya Ozawa; Kinuko Mitani; Yoshinobu Kanda; Shinji Nakao

doi:10.1182/bloodadvances.2024014855

Addition of romiplostim to immunosuppressive therapy as first-line treatment for patients with aplastic anemia

Jong Wook Lee
, Jun Ho Jang
, Hirohito Yamazaki
, Masashi Sawa
, Masahiro Kizaki
, Yoshiaki Tomiyama
, Koji Nagafuji
, Kensuke Usuki
, Jyh Pyng Gau
, Yasuyoshi Morita
, Jih Luh Tang
, Hung Chang
, Masayoshi Noshiro
, Akira Matsuda
, Keiya Ozawa
, Kinuko Mitani
, Yoshinobu Kanda
, Shinji Nakao

Hanyang University
Sungkyunkwan University
Kanazawa University
Anjo Kosei Hospital
Saitama Medical University
The University of Osaka
Kurume University
Teikyo University
Veterans General Hospital-Taipei
Kindai University
National Taiwan University
Chang Gung Medical Foundation – Linkou Branch
Kirin Holdings Co., Ltd.
Jichi Medical University
Dokkyo Medical University

Research output: Contribution to journal › Article › peer-review

5 Scopus citations

Original language	English
Pages (from-to)	5732-5735
Number of pages	4
Journal	Blood Advances
Volume	9
Issue number	22
DOIs	https://doi.org/10.1182/bloodadvances.2024014855
State	Published - 25 Nov 2025
Externally published	Yes

Access to Document

10.1182/bloodadvances.2024014855

Cite this

Lee, J. W., Jang, J. H., Yamazaki, H., Sawa, M., Kizaki, M., Tomiyama, Y., Nagafuji, K., Usuki, K., Gau, J. P., Morita, Y., Tang, J. L., Chang, H., Noshiro, M., Matsuda, A., Ozawa, K., Mitani, K., Kanda, Y., & Nakao, S. (2025). Addition of romiplostim to immunosuppressive therapy as first-line treatment for patients with aplastic anemia. Blood Advances, 9(22), 5732-5735. https://doi.org/10.1182/bloodadvances.2024014855

@article{bc0574eee42144b185d3a158fc5e7239,

title = "Addition of romiplostim to immunosuppressive therapy as first-line treatment for patients with aplastic anemia",

author = "Lee, \{Jong Wook\} and Jang, \{Jun Ho\} and Hirohito Yamazaki and Masashi Sawa and Masahiro Kizaki and Yoshiaki Tomiyama and Koji Nagafuji and Kensuke Usuki and Gau, \{Jyh Pyng\} and Yasuyoshi Morita and Tang, \{Jih Luh\} and Hung Chang and Masayoshi Noshiro and Akira Matsuda and Keiya Ozawa and Kinuko Mitani and Yoshinobu Kanda and Shinji Nakao",

year = "2025",

month = nov,

day = "25",

doi = "10.1182/bloodadvances.2024014855",

language = "English",

volume = "9",

pages = "5732--5735",

journal = "Blood Advances",

issn = "2473-9529",

publisher = "American Society of Hematology",

number = "22",

}

Lee, JW, Jang, JH, Yamazaki, H, Sawa, M, Kizaki, M, Tomiyama, Y, Nagafuji, K, Usuki, K, Gau, JP, Morita, Y, Tang, JL, Chang, H, Noshiro, M, Matsuda, A, Ozawa, K, Mitani, K, Kanda, Y & Nakao, S 2025, 'Addition of romiplostim to immunosuppressive therapy as first-line treatment for patients with aplastic anemia', Blood Advances, vol. 9, no. 22, pp. 5732-5735. https://doi.org/10.1182/bloodadvances.2024014855

TY - JOUR

T1 - Addition of romiplostim to immunosuppressive therapy as first-line treatment for patients with aplastic anemia

AU - Lee, Jong Wook

AU - Jang, Jun Ho

AU - Yamazaki, Hirohito

AU - Sawa, Masashi

AU - Kizaki, Masahiro

AU - Tomiyama, Yoshiaki

AU - Nagafuji, Koji

AU - Usuki, Kensuke

AU - Gau, Jyh Pyng

AU - Morita, Yasuyoshi

AU - Tang, Jih Luh

AU - Chang, Hung

AU - Noshiro, Masayoshi

AU - Matsuda, Akira

AU - Ozawa, Keiya

AU - Mitani, Kinuko

AU - Kanda, Yoshinobu

AU - Nakao, Shinji

PY - 2025/11/25

Y1 - 2025/11/25

UR - https://www.scopus.com/pages/publications/105021341524

U2 - 10.1182/bloodadvances.2024014855

DO - 10.1182/bloodadvances.2024014855

M3 - Article

C2 - 40758947

AN - SCOPUS:105021341524

SN - 2473-9529

VL - 9

SP - 5732

EP - 5735

JO - Blood Advances

JF - Blood Advances

IS - 22

ER -

Addition of romiplostim to immunosuppressive therapy as first-line treatment for patients with aplastic anemia

Access to Document

Other files and links

Cite this